Asian Development Bank (ADB)

Since the beginning of the pandemic at the start of 2020, ADB has committed more than $17.5 billion to help its developing member countries address the impacts of COVID-19 and address vaccination needs, and has mobilized a further $12.5 billion in cofinancing from partners.As the world kickstarts a sustainable recovery from COVID-19, ADB is delivering comprehensive support to meet Asia and the Pacific’s vaccine needs.Through a $9 billion Asia Pacific Vaccine Access... Read More

Since the beginning of the pandemic at the start of 2020, ADB has committed more than $17.5 billion to help its developing member countries address the impacts of COVID-19 and address vaccination needs, and has mobilized a further $12.5 billion in cofinancing from partners.

As the world kickstarts a sustainable recovery from COVID-19, ADB is delivering comprehensive support to meet Asia and the Pacific’s vaccine needs.

Through a $9 billion Asia Pacific Vaccine Access Facility, or APVAX, announced in December 2020, ADB is providing funding for vaccine procurement, logistics, and distribution.

Since the beginning of the pandemic at the start of 2020, ADB has committed more than $17.5 billion to help its developing member countries address the impacts of COVID-19 and address vaccination needs, and has mobilized a further $12.5 billion in cofinancing from partners.As the world kickstarts a sustainable recovery from COVID-19, ADB is delivering comprehensive support to meet Asia and the Pacific’s vaccine needs.Through a $9 billion Asia Pacific Vaccine Access... Read More